Upgrade to SI Premium - Free Trial

Marker Therapeutics (MRKR)

1.18 -0.06 (4.84%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

H.C. Wainwright Reiterates Buy Rating on Marker Therapeutics (MRKR) August 21, 2026 7:04 AM - StreetInsider Form 10-Q Marker Therapeutics, For: Jun 30 August 14, 2026 4:40 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Marker Therapeutics (MRKR) July 10, 2026 6:51 AM - StreetInsider Full Article List